Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Diabetes

Date Submitted: Oct 19, 2020
Date Accepted: Nov 7, 2021

The final, peer-reviewed published version of this preprint can be found here:

Evaluation of a Web Platform to Record Lifestyle Habits in Subjects at Risk of Developing Type 2 Diabetes in a Middle-Income Population: Prospective Interventional Study

Sevilla-Gonzalez MDR, Bourguet-Ramirez B, Lazaro-Carrera LS, Martagon-Rosado AJ, Gomez-Velasco DV, Viveros-Ruiz TL

Evaluation of a Web Platform to Record Lifestyle Habits in Subjects at Risk of Developing Type 2 Diabetes in a Middle-Income Population: Prospective Interventional Study

JMIR Diabetes 2022;7(1):e25105

DOI: 10.2196/25105

PMID: 35037888

PMCID: 8804949

Evaluation of a web platform to record lifestyle habits in subjects at risk of developing type 2 diabetes in a middle-income population

  • Magdalena Del Rocio Sevilla-Gonzalez; 
  • Brigette Bourguet-Ramirez; 
  • Laura Sofia Lazaro-Carrera; 
  • Alexandro J. Martagon-Rosado; 
  • Donaji Veronica Gomez-Velasco; 
  • Tannia Leticia Viveros-Ruiz

ABSTRACT

Background:

Lifestyle is the main focus of the Type 2 diabetes (T2D) prevention strategies. mHealth-based therapy has proved positive results for T2D prevention in high-income settings, but little is known about their effectiveness in low- and middle-income populations where the burden of T2D is substantial.

Objective:

We sought to identify barriers, feasibility, usability and effectiveness of an electronic platform “Visa Sana”, to record lifestyle habits in subjects at risk of developing type 2 diabetes in a middle-income setting.

Methods:

This was a 3-months prospective interventional study of subjects at risk of T2D (prediabetes and body mass index (BMI) between 24 kg/m2 and 40 kg/m2.) Feasibility was assessed by study retention. Usability was evaluated with the System Usability Scale (SUS). Effectiveness measures included changes in weight, body composition, BMI, glycated hemoglobin (HbA1c), and fasting blood glucose from baseline to 3-months visit. Lineal regression models were used to account for covariates.

Results:

The feasibility of Vida Sana was 42.8% (n=33 subjects), and the usability was 48.71% + 14.24. The barriers reported for not using the platform were difficulty for access to the platform (36.36%), lack of time to record their habits (34.09%) lack of interest to record their habits (18.18%), and lack of resources (11.36%) The platform was effective for lowering glucose in fasting (-3.18mg/dL vs -0.11+8.08; p = 0.038) and at 2hr (-16.97mg/dL vs 2.59 + 26.14; p = 0.045) , body fat percent (-1.36 (-2.23 – - 0.75) vs -1.02 (-1.92 - -0.31); p=0.024), and waist circumference (-3.92 + 5.13cm vs -1.73 + 5.01; p=0.023) independent their age, sex, treatment and education attainment.

Conclusions:

The use of an electronic platform was effective to improve glycemic and anthropometric parameters in a population at risk of developing diabetes. Improving accessibility and ease of navigation could be objectives to improve the acceptance of mobile applications in a middle-income population.


 Citation

Please cite as:

Sevilla-Gonzalez MDR, Bourguet-Ramirez B, Lazaro-Carrera LS, Martagon-Rosado AJ, Gomez-Velasco DV, Viveros-Ruiz TL

Evaluation of a Web Platform to Record Lifestyle Habits in Subjects at Risk of Developing Type 2 Diabetes in a Middle-Income Population: Prospective Interventional Study

JMIR Diabetes 2022;7(1):e25105

DOI: 10.2196/25105

PMID: 35037888

PMCID: 8804949

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.